Akèy › Maladi Crohn › North Carolina › Durham
Etid klinik pou Maladi Crohn nan Durham, NC
12 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote Durham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
Ap rekriteFaz 4
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi lwen
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Ap rekriteFaz 3
- University of North Carolina Medical Center ( Site 5034), Chapel Hill · 10 mi lwen
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi lwen
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 2/3
- University of North Carolina, Chapel Hill · 10 mi lwen
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Duke University Medical Center-Site Number: 8400093, Durham
- UNC Hospitals, The University of North Carolina at Chapel Hill-Site Number: 8400074, Chapel Hill · 10 mi lwen
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- UNC Hospitals, The University of North Carolina at Chapel Hill-Site Number: 8400074, Chapel Hill · 10 mi lwen
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- University of North Carolina Hospital, Chapel Hill · 10 mi lwen
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
Ap rekriteEtid obsèvasyon
- University of North Carolina, Chapel Hill · 10 mi lwen
Comparing Over the Counter Pain Medicines for Discomfort in Crohn's Disease (AVID-CD)
Ap rekrite
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi lwen
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Univ NC Chapel Hill /ID# 262198, Chapel Hill · 10 mi lwen
COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)
Ap rekriteEtid obsèvasyon
- Duke Health System, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi lwen
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Ap rekriteFaz 2
- Investigational Site Number: 8400003, Chapel Hill · 10 mi lwen
Etid Maladi Crohn nan lòt vil
- New York City, NY35 etid
- Boston, MA19 etid
- Miami, FL19 etid
- Cleveland, OH19 etid
- St. Louis, MO19 etid
- Tyler, TX17 etid
- Houston, TX17 etid
- Orlando, FL17 etid
- Atlanta, GA17 etid
- San Antonio, TX15 etid
- San Diego, CA15 etid
- Los Angeles, CA15 etid
Lòt etid nan Durham
- Kansè nan tete64 etid
- Kansè (tout kalite)58 etid
- Kansè Poumon ki pa ti selil39 etid
- Myelom Miltip37 etid
- Leksemi mieloïd egi33 etid
- Kansè Metastatik33 etid
- Kansè pwostat32 etid
- Kansè poumon32 etid
- Kansè kolorektal28 etid
- Kansè ovè27 etid
- Lukemi lenfositè kwonik27 etid
- Ensifizyans kadyak26 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.